SCHEMBL796277

SCHEMBL796277

Oc1cc(-c2nc3ccc(I)cc3s2)ccc1OCCF

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
KDM4E B2RXH2 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
TP53 P04637 2/20 0.48
MEN1 O00255 1/20 0.48
HCRTR1 O43613 1/20 0.48
MAPK1 P28482 1/20 0.48
BLM P54132 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48
APP P05067 12/20 0.47
GLA P06280 2/20 0.43
SULT1A1 P50225 2/20 0.41
GAA P10253 1/20 0.40
PPARG P37231 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL796269 0.88 APP (0.55) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL796559 0.85 MAPT (0.67) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL13198317 0.77 APP (0.53) MAPTAPPSULT1A1
SCHEMBL11195073 0.73 APP (0.60) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL13198323 0.71 SMN1; SMN2 (0.54) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL796265 0.69 MAPT (0.74) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL29217751 0.69 KDM4E (0.72) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL13806251 0.69 APP (0.67) MAPTAPPGLASULT1A1GAA
SCHEMBL30884120 0.69 KDM4E (0.72) MAPTKDM4ESMN1; SMN2NPC1KMT2A
SCHEMBL13255957 0.68 APP (0.68) MAPTKDM4ESMN1; SMN2NPC1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
EP-2218464-A1 Compounds for non-invasive measurement of aggregates of amyloid peptides Technische Universität München (DE) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT MAPT 10/4885KDM4E 4716/4885SMN1; SMN2 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.